Lipoxins: nature’s way to resolve inflammation

References

• SerhanCNSavillJResolution of inflammation: the beginning programs the endNat Immunol20056121191119716369558
   PubMed Web of Science ®Google Scholar
• FierroIMSerhanCNMechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxinsBraz J Med Biol Res200134555556611323741
   PubMed Web of Science ®Google Scholar
• SerhanCNHambergMSamuelssonBLipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytesProc Natl Acad Sci U S A19848117533553396089195
   PubMed Web of Science ®Google Scholar
• HambergMSamuelssonBProstaglandin endoperoxides. Novel transformations of arachidonic acid in human plateletsProc Natl Acad Sci U S A1974719340034044215079
   PubMed Web of Science ®Google Scholar
• MalhotraSDeshmukhSSDastidarSGCOX inhibitors for airway inflammationExpert Opin Ther Targets201216219520722324934
   PubMed Web of Science ®Google Scholar
• SerhanCNSheppardKALipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitroJ Clin Invest19908537727802155925
   PubMed Web of Science ®Google Scholar
• ClariaJSerhanCNAspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactionsProc Natl Acad Sci U S A19959221947594797568157
   PubMed Web of Science ®Google Scholar
• ChengTIChengTJChiangSCAssociation of aspirin with eosinophilia in peripheral bloodAnn Pharmacother200438122172217315536142
   PubMed Web of Science ®Google Scholar
• ChiangNSerhanCNAspirin triggers formation of anti-inflammatory mediators: new mechanism for an old drugDiscov Med200442447047520704950
   PubMedGoogle Scholar
• FanSYZengHWPeiYHThe anti-inflammatory activities of an extract and compounds isolated from Platycladus orientalis (Linnaeus) Franco in vitro and ex vivoJ Ethnopharmacol2012141264765221619922
   PubMed Web of Science ®Google Scholar
• ChiangNHurwitzSRidkerPMSerhanCNAspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trialArterioscler Thromb Vasc Biol2006262e14e1716293793
   PubMed Web of Science ®Google Scholar
• RussellRGoriIPellegriniCKumarRAchtariCCannyGOLipoxin A4 is a novel estrogen receptor modulatorFASEB J201125124326433721885654
   PubMed Web of Science ®Google Scholar
• CannyGOLesseyBAThe role of lipoxin A4 in endometrial biology and endometriosisMucosal Immunol20136343945023485944
   PubMed Web of Science ®Google Scholar
• BirnbaumYYeYLinYAugmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the ratCirculation2006114992993516908763
   PubMed Web of Science ®Google Scholar
• PlanagumaAPfefferMARubinGLovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4Mucosal Immunol20103327027920130564
   PubMed Web of Science ®Google Scholar
• LevyBDMyocardial 15-epi-lipoxin A4 generation provides a new mechanism for the immunomodulatory effects of statins and thiazolidinedionesCirculation2006114987387516940203
   PubMed Web of Science ®Google Scholar
• SerhanCNLevyBDClishCBGronertKChiangNLipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunityErnst Schering Res Found Workshop20003114318510943332
   PubMedGoogle Scholar
• SchaldachCMRibyJBjeldanesLFLipoxin A4: a new class of ligand for the Ah receptorBiochemistry199938237594760010360957
   PubMed Web of Science ®Google Scholar
• GronertKMartinsson-NiskanenTRavasiSChiangNSerhanCNSelectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responsesAm J Pathol200115813911141472
   PubMed Web of Science ®Google Scholar
• PapayianniASerhanCNPhillipsMLRennkeHGBradyHRTranscellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritisKidney Int1995475129513027543622
   PubMed Web of Science ®Google Scholar
• ChiangNBermudezEARidkerPMHurwitzSSerhanCNAspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trialProc Natl Acad Sci U S A200410142151781518315471991
   PubMed Web of Science ®Google Scholar
• RidkerPMCookNRLeeIMA randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in womenN Engl J Med2005352131293130415753114
   PubMed Web of Science ®Google Scholar
• RothbergMBCelestinCFioreLDLawlerECookJRWarfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefitAnn Intern Med2005143424125016103468
   PubMed Web of Science ®Google Scholar
• CookNRLeeIMGazianoJMLow-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trialJAMA20052941475515998890
   PubMed Web of Science ®Google Scholar
• GiovannucciEEganKMHunterDJAspirin and the risk of colorectal cancer in womenN Engl J Med1995333106096147637720
   PubMed Web of Science ®Google Scholar
• YinHLiuWGoleniewskaKPorterNAMorrowJDPeeblesRSJrDietary supplementation of omega-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammationFree Radic Biol Med200947562262819501157
   PubMed Web of Science ®Google Scholar
• IsaksonPSeibertKMasferrerJSalveminiDLeeLNeedlemanPDiscovery of a better aspirinAdv Prostaglandin Thromboxane Leukot Res19952349547732896
   PubMedGoogle Scholar
• ChiangNTakanoTClishCBPetasisNATaiHHSerhanCNAspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISAJ Pharmacol Exp Ther199828727797909808710
   PubMed Web of Science ®Google Scholar
• SchotteliusAJGiesenCAsadullahKAn aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profileJ Immunol2002169127063707012471142
   PubMed Web of Science ®Google Scholar
• SerhanCNEicosanoids in leukocyte functionCurr Opin Hematol19941169779371262
   PubMedGoogle Scholar
• SerhanCNLipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?Prostaglandins19975321071379112289
   PubMed Web of Science ®Google Scholar
• SerhanCNLipoxin metabolism by human promyelocytic leukemia (HL-60) cellsAdv Exp Med Biol1997400B6416469547615
   PubMed Web of Science ®Google Scholar
• SerhanCNSystems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediatorsProstaglandins Leukot Essent Fatty Acids2008793–515716319008087
   PubMed Web of Science ®Google Scholar
• SerhanCNChiangNNovel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomicsRheum Dis Clin North Am2004301699515061569
   PubMed Web of Science ®Google Scholar
• SerhanCNChiangNEndogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genusBr J Pharmacol2008153Suppl 1S200S21517965751
   PubMed Web of Science ®Google Scholar
• SerhanCNChiangNVan DykeTEResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNat Rev Immunol20088534936118437155
   PubMed Web of Science ®Google Scholar
• SerhanCNFierroIMChiangNPouliotMCutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin- triggered-15-epi-lipoxin A4J Immunol200116663650365411238602
   PubMed Web of Science ®Google Scholar
• BakerNO’MearaSJScannellMMadernaPGodsonCLipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cellsJ Immunol200918263819382619265161
   PubMed Web of Science ®Google Scholar
• MadernaPCottellDCToivonenTFPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosisFASEB J201024114240424920570963
   PubMed Web of Science ®Google Scholar
• MitchellSThomasGHarveyKLipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivoJ Am Soc Nephrol200213102497250712239238
   PubMed Web of Science ®Google Scholar
• DirixCEHogervorstJGRumpPHendriksJJBruinsMHornstraGPrenatal arachidonic acid exposure and selected immune-related variables in childhoodBr J Nutr2009102338739719173768
   PubMed Web of Science ®Google Scholar
• RadmarkOSamuelssonB5-Lipoxygenase: mechanisms of regulationJ Lipid Res200950SupplS40S4518987389
   PubMed Web of Science ®Google Scholar
• O’BryanLPinkstonPKumaraswamiVLocalized eosinophil degranulation mediates disease in tropical pulmonary eosinophiliaInfect Immun20037131337134212595450
   PubMed Web of Science ®Google Scholar
• LuscinskasFWNicolaouKCWebberSEVealeCAGimbroneMAJrSerhanCNCa2+ mobilization with leukotriene A4 and epoxytetraenes in human neutrophilsBiochem Pharmacol19903923553652154229
   PubMed Web of Science ®Google Scholar
• DixitNSimonSIChemokines, selectins and intracellular calcium flux: temporal and spatial cues for leukocyte arrestFront Immunol2012318822787461
   PubMed Web of Science ®Google Scholar
• WeissSJTissue destruction by neutrophilsN Engl J Med198932063653762536474
   PubMed Web of Science ®Google Scholar
• Matute-BelloGLilesWCRadellaF2ndNeutrophil apoptosis in the acute respiratory distress syndromeAm J Respir Crit Care Med19971566196919779412582
   PubMed Web of Science ®Google Scholar
• AndzinskiLWuCFLienenklausSKrogerAWeissSJablonskaJDelayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN-betaInt J Cancer2015136357258324806531
   PubMed Web of Science ®Google Scholar
• El KebirDJozsefLPanWFilepJGMyeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammationCirc Res2008103435235918617697
   PubMed Web of Science ®Google Scholar
• KlebanoffSJMyeloperoxidase: friend and foeJ Leukoc Biol200577559862515689384
   PubMed Web of Science ®Google Scholar
• El KebirDJozsefLPanW15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injuryAm J Respir Crit Care Med2009180431131919483113
   PubMed Web of Science ®Google Scholar
• El KebirDJozsefLKhreissTAspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammationJ Immunol2007179161662217579083
   PubMed Web of Science ®Google Scholar
• HooperDCScottGSZborekAUric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosisFASEB J200014569169810744626
   PubMed Web of Science ®Google Scholar
• BeckmanJSBeckmanTWChenJMarshallPAFreemanBAApparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxideProc Natl Acad Sci U S A1990874162016242154753
   PubMed Web of Science ®Google Scholar
• JozsefLZoukiCPetasisNASerhanCNFilepJGLipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytesProc Natl Acad Sci U S A20029920132661327112235371
   PubMed Web of Science ®Google Scholar
• ZoukiCJozsefLOuelletSPaquetteYFilepJGPeroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytesJ Leukoc Biol200169581582411358991
   PubMed Web of Science ®Google Scholar
• FilepJGBeauchampMBaronCPaquetteYPeroxynitrite mediates IL-8 gene expression and production in lipopolysaccharide-stimulated human whole bloodJ Immunol199816110565656629820546
   PubMed Web of Science ®Google Scholar
• AprileALucarelliSVagnucciBFredianiTThe use of anti-leukotrienes in paediatricsEur Rev Med Pharmacol Sci200152535711863319
   PubMedGoogle Scholar
• PrietoPCuencaJTravesPGFernandez-VelascoMMartin-SanzPBoscaLLipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathwaysCell Death Differ20101771179118820094061
   PubMed Web of Science ®Google Scholar
• KhatamiMUnresolved inflammation: ‘immune tsunami’ or erosion of integrity in immune-privileged and immune-responsive tissues and acute and chronic inflammatory diseases or cancerExpert Opin Biol Ther201111111419143221663532
   PubMed Web of Science ®Google Scholar
• O’SullivanSOn the role of PGD2 metabolites as markers of mast cell activation in asthmaActa Physiol Scand Suppl199964417410352758
   PubMedGoogle Scholar
• RamonSBancosSSerhanCNPhippsRPLipoxin A(4) modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanismEur J Immunol201444235736924166736
   PubMed Web of Science ®Google Scholar
• ArielAChiangNAritaMPetasisNASerhanCNAspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cellsJ Immunol2003170126266627212794159
   PubMed Web of Science ®Google Scholar
• LevyBDFokinVVClarkJMWakelamMJPetasisNASerhanCNPolyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a ‘stop’ signaling switch for aspirin-triggered lipoxin A4FASEB J199913890391110224233
   PubMed Web of Science ®Google Scholar
• LiuYKachAZieglerUThe role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney diseasePLoS One201388e7317324009738
   PubMed Web of Science ®Google Scholar
• BarnesPJKarinMNuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseasesN Engl J Med199733615106610719091804
   PubMed Web of Science ®Google Scholar
• DeckerELNehmannNKampenEEibelHZipfelPFSkerkaCEarly growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expressionNucleic Acids Res200331391192112560487
   PubMed Web of Science ®Google Scholar
• ParraEFerreiraJOrtegaAOverexpression of EGR-1 modulates the activity of NF-kappaB and AP-1 in prostate carcinoma PC-3 and LNCaP cell linesInt J Oncol201139234535221617851
   PubMed Web of Science ®Google Scholar
• ThielGKaufmannKMaginALietzMBachKCramerMThe human transcriptional repressor protein NAB1: expression and biological activityBiochim Biophys Acta20001493328930111018254
   PubMed Web of Science ®Google Scholar
• QiuFHDevchandPRWadaKSerhanCNAspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophilsFASEB J200115142736273811687510
   PubMed Web of Science ®Google Scholar
• DelerivePDe BosscherKBesnardSPeroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1J Biol Chem199927445320483205410542237
   PubMed Web of Science ®Google Scholar
• WeinbergerBQuizonCVetranoAMArcherFLaskinJDLaskinDLMechanisms mediating reduced responsiveness of neonatal neutrophils to lipoxin A4Pediatr Res200864439339818535486
   PubMed Web of Science ®Google Scholar
• KjeldsenLCowlandJBBorregaardNHuman neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouseBiochim Biophys Acta200014821–227228311058768
   PubMed Web of Science ®Google Scholar
• HirstSJLeeTHAirway smooth muscle as a target of glucocorticoid action in the treatment of asthmaAm J Respir Crit Care Med19981585 Pt 3S201S2069817746
   PubMed Web of Science ®Google Scholar
• van der VeldenVHGlucocorticoids: mechanisms of action and anti-inflammatory potential in asthmaMediators Inflamm1998742292379792333
   PubMed Web of Science ®Google Scholar
• NagaiHTanakaHThe role of cytokines and arachidonic acid metabolites in the development of airway hyperresponsivenessNihon Yakurigaku Zasshi19981114233241 Japanese9618708
   PubMedGoogle Scholar
• ItohKMochizukiMIshiiYTranscription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2)Mol Cell Biol2004241364514673141
   PubMed Web of Science ®Google Scholar
• Medina AvalosMAOrea SolanoMMacrophages in asthmaRev Alerg Mex19974451351399432275
   PubMedGoogle Scholar
• BorgesonEGodsonCMolecular circuits of resolution in renal diseaseScientific World Journal2010101370138520623097
   PubMed Web of Science ®Google Scholar
• MadernaPGodsonCLipoxins: resolutionary roadBr J Pharmacol2009158494795919785661
   PubMed Web of Science ®Google Scholar
• BochnerBSUndemBJLichtensteinLMImmunological aspects of allergic asthmaAnnu Rev Immunol1994122953358011284
   PubMed Web of Science ®Google Scholar
• BrennanEPNolanKABorgesonELipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1J Am Soc Nephrol201324462763723520204
   PubMed Web of Science ®Google Scholar
• KieranNEDoranPPConnollySBModification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analogKidney Int200364248049212846743
   PubMed Web of Science ®Google Scholar
• MachadoFSJohndrowJEEsperLAnti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependentNat Med200612333033416415877
   PubMed Web of Science ®Google Scholar
• YoshimuraASuzukiMSakaguchiRHanadaTYasukawaHSOCS, inflammation, and autoimmunityFront Immunol201232022566904
   PubMed Web of Science ®Google Scholar
• UndernerMBoitaFPatteFMode of action of corticoids in asthmaRev Pneumol Clin19864241731823024294
   PubMedGoogle Scholar
• QuerfurthHWLaFerlaFMAlzheimer’s diseaseN Engl J Med2010362432934420107219
   PubMed Web of Science ®Google Scholar
• HuSMao-YingQLWangJLipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokinesJ Neuroinflammation2012927823268791
   PubMed Web of Science ®Google Scholar
• Guerrero-PlataAOrtegaEGomezBPersistence of respiratory syncytial virus in macrophages alters phagocytosis and pro- inflammatory cytokine productionViral Immunol2001141193011270594
   PubMed Web of Science ®Google Scholar
• BannenbergGMoussignacRLGronertKLipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administrationBr J Pharmacol20041431435215302682
   PubMed Web of Science ®Google Scholar
• ClariaJRegulation of cell proliferation and apoptosis by bioactive lipid mediatorsRecent Pat Anticancer Drug Discov20061336938218221047
   PubMed Web of Science ®Google Scholar
• ClariaJRomanoMPharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancerCurr Pharm Des200511263431344716250846
   PubMed Web of Science ®Google Scholar
• VieiraAMNetoEHFigueiredoCCBarja FidalgoCFierroIMMorandiVATL-1, a synthetic analog of lipoxin, modulates endothelial permeability and interaction with tumor cells through a VEGF-dependent mechanismBiochem Pharmacol201490438839624887589
   PubMed Web of Science ®Google Scholar
• DingCYanJRegulation of autoreactive B cells: checkpoints and activationArch Immunol Ther Exp20075528389
   Web of Science ®Google Scholar
• YiZBishopGARegulatory role of CD40 in obesity-induced insulin resistanceAdipocyte201541656926167405
   PubMed Web of Science ®Google Scholar
• RatikanJAMicewiczEDXieMWSchaueDRadiation takes its TollCancer Lett2015
   Web of Science ®Google Scholar
• LiuGAbrahamEMicroRNAs in immune response and macrophage polarizationArterioscler Thromb Vasc Biol201333217017723325473
   PubMed Web of Science ®Google Scholar
• ArltASchaferHKalthoffHThe ‘N-factors’ in pancreatic cancer: functional relevance of NF-kappaB, NFAT and Nrf2 in pancreatic cancerOncogenesis20121e3523552468
   PubMed Web of Science ®Google Scholar
• JanakiramNBMohammedARaoCVRole of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancerCancer Metastasis Rev2011303–450752322015691
   PubMed Web of Science ®Google Scholar
• Garcia-AlbenizXChanATAspirin for the prevention of colorectal cancerBest practice and research. Clin Gastroenterol2011254–5461472
   PubMed Web of Science ®Google Scholar
• WenzelSEArachidonic acid metabolites: mediators of inflammation in asthmaPharmacotherapy1997171 Pt 23S12S9017783
   PubMed Web of Science ®Google Scholar
• LewisRARobinJLArachidonic acid derivatives as mediators of asthmaJ Allergy Clin Immunol1985762 Pt 22592643926852
   PubMed Web of Science ®Google Scholar
• OnoEDutileSKazaniSLipoxin generation is related to soluble epoxide hydrolase activity in severe asthmaAm J Respir Crit Care Med2014190888689725162465
   PubMed Web of Science ®Google Scholar
• LevyBDSerhanCNExploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin-triggered lipid mediatorsDrugs Today (Barc)200339537338412861350
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLCaleroCRojanoBC-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control studyInt J Med Sci201310893894723801879
   PubMed Web of Science ®Google Scholar
• BozinovskiSUddinMVlahosRSerum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary diseaseProc Natl Acad Sci U S A2012109393594022215599
   PubMed Web of Science ®Google Scholar
• LevyBDSerhanCNResolution of acute inflammation in the lungAnnu Rev Physiol20147646749224313723
   PubMed Web of Science ®Google Scholar
• SolitoESastreMMicroglia function in Alzheimer’s diseaseFront Pharmacol201231422363284
   PubMed Web of Science ®Google Scholar
• MedeirosRKitazawaMPassosGFAspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in miceAm J Pathol201318251780178923506847
   PubMed Web of Science ®Google Scholar
• MoskowitzMAKiwakKJHekimianKLevineLSynthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusionScience. 2519842244651886889
   Web of Science ®Google Scholar
• FlamandNLuoMPeters-GoldenMBrockTGPhosphorylation of serine 271 on 5-lipoxygenase and its role in nuclear exportJ Biol Chem2009284130631318978352
   PubMed Web of Science ®Google Scholar
• WuLMiaoSZouLBLipoxin A4 inhibits 5-lipoxygenase trans-location and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injuryJ Mol Neurosci201248118520022661361
   PubMed Web of Science ®Google Scholar
• LuoCLLiQQChenXPLipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injuryBrain Res2013150211023370001
   PubMed Web of Science ®Google Scholar
• de JongMDH5N1 transmission and disease: observations from the frontlinesPediatr Infect Dis J20082710 SupplS54S5618820578
   PubMed Web of Science ®Google Scholar
• CillonizCPantin-JackwoodMJNiCLethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infectionJ Virol201084157613762420504916
   PubMed Web of Science ®Google Scholar
• Rivera-ToledoEGomezBRespiratory syncytial virus persistence in macrophages alters the profile of cellular gene expressionViruses20124123270328023342359
   PubMed Web of Science ®Google Scholar
• ZhangLPeeplesMEBoucherRCCollinsPLPicklesRJRespiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathologyJ Virol200276115654566611991994
   PubMed Web of Science ®Google Scholar
• RichardsonJYOttoliniMGPletnevaLRespiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapyJ Immunol200517474356436415778400
   PubMed Web of Science ®Google Scholar
• ShireyKAPletnevaLMPucheACControl of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependentMucosal Immunol20103329130020404812
   PubMed Web of Science ®Google Scholar
• ShireyKALaiWPletnevaLMRole of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathologyMucosal Immun201473549557
   Web of Science ®Google Scholar
• SugawaraYMakuuchiMTakadaKDetection of Epstein-Barr virus DNA in hepatocellular carcinoma tissues from hepatitis C-positive patientsScand J Gastroenterol200035998198411063161
   PubMed Web of Science ®Google Scholar
• SugawaraYMizugakiYUchidaTDetection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expressionVirology1999256219620210191184
   PubMed Web of Science ®Google Scholar
• HarabuchiYYamanakaNKatauraAEpstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granulomaLancet199033586821281301967431
   PubMed Web of Science ®Google Scholar
• YoungLSRickinsonABEpstein-Barr virus: 40 years onNat Rev Cancer200441075776815510157
   PubMed Web of Science ®Google Scholar
• WestphalEMBlackstockWFengWIsraelBKenneySCActivation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignanciesCancer Res200060205781578811059774
   PubMed Web of Science ®Google Scholar
• ShuklaSMacLennanGTFuPNuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progressionNeoplasia20046439040015256061
   PubMed Web of Science ®Google Scholar
• KarinMLinANF-kappaB at the crossroads of life and deathNat Immunol20023322122711875461
   PubMed Web of Science ®Google Scholar
• PrinceSKeatingSFieldingCBrennanPFloettmannERoweMLatent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanismsJ Virol20037785000500712663807
   PubMed Web of Science ®Google Scholar
• HerreroJAMathewPPayaCVLMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alphaJ Virol1995694216821747884865
   PubMed Web of Science ®Google Scholar
• HuenDSHendersonSACroom-CarterDRoweMThe Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domainOncogene19951035495607845680
   PubMed Web of Science ®Google Scholar
• MitchellTSugdenBStimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virusJ Virol1995695296829767707523
   PubMed Web of Science ®Google Scholar
• YinLLiaoWDengXLMP1 activates NF-kappa B via degradation of I kappa B alpha in nasopharyngeal carcinoma cellsChin Med J (Engl)2001114771872211780335
   PubMed Web of Science ®Google Scholar
• LiuSFWangHLiZJAspirin induces lytic cytotoxicity in Epstein-Barr virus–positive cellsEur J Pharmacol20085891–381318571159
   PubMed Web of Science ®Google Scholar
• AblashiDVChatlynneLGWhitmanJEJrCesarmanESpectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseasesClin Microbiol Rev200215343946412097251
   PubMed Web of Science ®Google Scholar
• CesarmanEKnowlesDMThe role of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseasesSemin Cancer Biol19999316517410343068
   PubMed Web of Science ®Google Scholar
• ChangYCesarmanEPessinMSIdentification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcomaScience19942665192186518697997879
   PubMed Web of Science ®Google Scholar
• BoshoffCWeissRAKaposi’s sarcoma-associated herpesvirusAdv Cancer Res19987557869709807
   PubMed Web of Science ®Google Scholar
• CesarmanEChangYMoorePSSaidJWKnowlesDMKaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomasN Engl J Med199533218118611917700311
   PubMed Web of Science ®Google Scholar
• KellerSASchattnerEJCesarmanEInhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cellsBlood20009672537254211001908
   PubMed Web of Science ®Google Scholar
• LeiXBaiZYeFRegulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNANat Cell Biol201012219319920081837
   PubMed Web of Science ®Google Scholar
• PaulAGSharma-WaliaNChandranBTargeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphomaPLoS One201169e2437921980345
   PubMed Web of Science ®Google Scholar
• George PaulASharma-WaliaNKerurNWhiteCChandranBPiracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi’s sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogenCancer Res20107093697370820388794
   PubMed Web of Science ®Google Scholar
• Sharma-WaliaNPaulAGBotteroVKaposi’s sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasionPLoS Pathog201062e100077720169190
   PubMed Web of Science ®Google Scholar
• Sharma-WaliaNRaghuHSadagopanSCyclooxygenase 2 induced by Kaposi’s sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expressionJ Virol200680136534655216775340
   PubMed Web of Science ®Google Scholar
• Sharma-WaliaNChandranKPatelKVeettilMVMargineanAThe Kaposi’s sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesisJ Virol20148842131215624335295
   PubMed Web of Science ®Google Scholar
• PaulAGChandranBSharma-WaliaNCyclooxygenase-2- prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi’s sarcoma-associated herpes virus associated malignanciesTransl Res20131622779223567332
   PubMed Web of Science ®Google Scholar
• PaulAGChandranBSharma-WaliaNConcurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi’s sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell linesTransl Res2013161644746823523954
   PubMed Web of Science ®Google Scholar
• Sharma-WaliaNPatelKChandranKCOX-2/PGE2: molecular ambassadors of Kaposi’s sarcoma-associated herpes virus oncoprotein-v-FLIPOncogenesis20121e523552603
   PubMed Web of Science ®Google Scholar
• Sharma-WaliaNGeorge PaulAPatelKChandranKAhmadWChandranBNFAT and CREB regulate Kaposi’s sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)J Virol20108424127331275320943963
   PubMed Web of Science ®Google Scholar
• MargineanASharma-WaliaNLipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi’s sarcoma cellsTransl Res2015166211113325814167
   PubMed Web of Science ®Google Scholar
• FolkmanJTumor angiogenesis: therapeutic implicationsN Engl J Med197128521118211864938153
   PubMed Web of Science ®Google Scholar
• MasoodIPorterKELondonNJEndothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous veinBr J Surg19978444995039112901
   PubMed Web of Science ®Google Scholar
• MasoodRCaiJZhengTSmithDLNaiduYGillPSVascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcomaProc Natl Acad Sci U S A19979439799849023368
   PubMed Web of Science ®Google Scholar
• MasoodRXiaGSmithDLEphrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endotheliumBlood200510531310131815471957
   PubMed Web of Science ®Google Scholar
• MasoodRZhengTTupuleAKaposi’s sarcoma-associated herpesvirus infection and multiple myelomaScience1997278534519701971 author reply 1972–19739417643
   PubMed Web of Science ®Google Scholar
• KieranMWKalluriRChoYJThe VEGF pathway in cancer and disease: responses, resistance, and the path forwardCold Spring Harb Perspect Med2012212a00659323209176
   PubMed Web of Science ®Google Scholar
• AlghisiGCRueggCVascular integrins in tumor angiogenesis: mediators and therapeutic targetsEndothelium200613211313516728329
   PubMed Web of Science ®Google Scholar
• SivakumarRSharma-WaliaNRaghuHKaposi’s sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implicationsJ Virol20088241759177618057235
   PubMed Web of Science ®Google Scholar
• FordPWHamdenKEWhitmanAGMcCubreyJAAkulaSMVascular endothelial growth factor augments human herpesvirus-8 (HHV-8/KSHV) infectionCancer Biol Ther20043987688115254407
   PubMed Web of Science ®Google Scholar
• WangLWakisakaNTomlinsonCCThe Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factorsCancer Res20046482774278115087393
   PubMed Web of Science ®Google Scholar
• MilesSARezaiARSalazar-GonzalezJFAIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6Proc Natl Acad Sci U S A19908711406840721693429
   PubMed Web of Science ®Google Scholar
• LiXLiangDLinXRobertsonESLanKKaposi’s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65J Virol201185178606861521697472
   PubMed Web of Science ®Google Scholar
• Arav-BogerRTreatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishmentsVirus Genes200938219520319139983
   PubMed Web of Science ®Google Scholar
• CoenNDuraffourSSnoeckRAndreiGKSHV targeted therapy: an update on inhibitors of viral lytic replicationViruses20146114731475925421895
   PubMed Web of Science ®Google Scholar
• UldrickTSWhitbyDUpdate on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi SarcomaCancer Lett2011305215016221377267
   PubMed Web of Science ®Google Scholar
• FunkCDFitzGeraldGACOX-2 inhibitors and cardiovascular riskJ Cardiovasc Pharmacol200750547047918030055
   PubMed Web of Science ®Google Scholar
• SharaMStohsSJEfficacy and safety of white willow bark (Salix alba) extractsPhytother Res20152981112111625997859
   PubMed Web of Science ®Google Scholar
• JanakiramNBRaoCVRole of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancerCurr Mol Med20099556557919601807
   PubMed Web of Science ®Google Scholar